Search keyWord :

Hankyung.com introduces: Unmissable BFCM Deal on Amazon: Get EXTREME DUAL ARGININE PLUS, Free Shipping, and Subscribe & Save Options!

Nov 20, 2024

https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.jpg Photo: 1,000mg x 120 Tablets,2 Months Supply,Boost up Energy & Vitality for Men\'s Sports Performance

TRACE International Releases the 2024 Bribery Risk Matrix

Nov 20, 2024

ANNAPOLIS,Md.,Nov. 19,2024-- TRACE,a non-profit international business association dedicated to anti-bribery,compliance,and good governance,has released the 2024Bribery Risk Matrix,measuring business

Xinhua Silk Road: E. China's fishing village recognized as Best Tourism Village by UN Tourism

Nov 20, 2024

BEIJING,Nov. 19,2024-- Yandunjiao Village in east China\'s Shandong Province and six other Chinese villages were announced as Best Tourism Villages by the United Nations World Tourism Organization (UN

Quantinuum Named Winner in Fast Company's 2024 Next Big Things in Tech Awards

Nov 20, 2024

The System Model H-2 quantum processor hailed as the \'Next Big Thing in Tech\' at the fourth annual Fast Company Awards.

Xinhua Silk Road: Inheriting traditions while promoting innovation, Chinese pharmaceutical company contributes to TCM globalization

Nov 20, 2024

BEIJING,Nov. 19,2024-- With continuous advancement of the Belt and Road Initiative,Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd. has been actively promoting the globalization of traditional Chinese

Health2Sync Partners with Singapore Health Promotion Board and Abbott to Launch Innovative DigiCoach Program Tackling Pre-diabetes and Obesity

Nov 20, 2024

"DigiCoach program" is a pilot program by Singapore Health Promotion Board,Health2Sync,and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of di

Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD's The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA

Nov 20, 2024

48-week end-of-treatment data from theongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination with PEG-IFNα

Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study

Nov 20, 2024

Highlights: Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS)

Digital Medicine Society Launches Resources to Navigate Global Digital Health Regulatory Pathways

Nov 20, 2024

Resources will speed the expansion of digital health products worldwide,improving global patient access

Envision Energy SVP Kane Xu Highlights Technology Innovation as a Key Driver for Renewable Energy at COP29

Nov 20, 2024

BAKU,Azerbaijan,Nov. 19,2024-- The 29th Conference of the Parties to the UN Framework Convention on Climate Change (COP29) is underway in Baku,Azerbaijan. Kane Xu,Senior Vice President of Envision Ene

1 ... 735 736 737 738 739 740 741 ... 1256